Philip Kaye

Philip Kaye (born December 1931) is a British businessman and restaurateur, and the founder of the Garfunkel's Restaurant casual dining chain. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'Philip Kaye', query time: 0.03s Refine Results
  1. 1
    Successful Treatment of an Early Barrett's Adenocarcinoma in a High-Risk Patient with Portal Hypertension: The “Band and Leave” Strategy

    Successful Treatment of an Early Barrett's Adenocarcinoma in a High-Risk Patient with Portal Hypertension: The “Band and Leave” Strategy by Miguel Fraile-López, Jacobo Ortiz-Fernández-Sordo, Martin James, Philip Kaye, Krish Ragunath

    Published 2022-03-01
    Get full text
    Article
  2. 2
    Study to investigate the prevalence of human papillomavirus in Barrett’s oesophagus using a novel screening methodology

    Study to investigate the prevalence of human papillomavirus in Barrett’s oesophagus using a novel screening methodology by Krish Ragunath, Philip Kaye, Gillian Knight, Elizabeth Marsh, Jonathan Richard White, Aimee Whitton

    Published 2022-07-01
    Get full text
    Article
  3. 3
    Orbital Inflammatory Complications of Crohn’s Disease: A Rare Case Series

    Orbital Inflammatory Complications of Crohn’s Disease: A Rare Case Series by Tanya M Monaghan, Giorgio Albanese, Philip Kaye, James D Thomas, Lorraine C Abercrombie, Gordon W Moran

    Published 2018-02-01
    Get full text
    Article
  4. 4
    Role of Hepatocyte Senescence in the Activation of Hepatic Stellate Cells and Liver Fibrosis Progression

    Role of Hepatocyte Senescence in the Activation of Hepatic Stellate Cells and Liver Fibrosis Progression by Pramudi Wijayasiri, Stuart Astbury, Philip Kaye, Fiona Oakley, Graeme J. Alexander, Timothy J. Kendall, Aloysious D. Aravinthan

    Published 2022-07-01
    Get full text
    Article
  5. 5
    Biomarkers of Type IV Collagen Turnover Reflect Disease Activity in Patients with Early-Stage Non-Alcoholic Fatty Liver (NAFL)

    Biomarkers of Type IV Collagen Turnover Reflect Disease Activity in Patients with Early-Stage Non-Alcoholic Fatty Liver (NAFL) by Ida Lønsmann, Jane I. Grove, Asma Haider, Philip Kaye, Morten A. Karsdal, Diana J. Leeming, Guruprasad P. Aithal

    Published 2023-08-01
    Get full text
    Article
  6. 6
    Next-generation sequencing of pancreatic cyst wall specimens obtained using micro-forceps for improving diagnostic accuracy

    Next-generation sequencing of pancreatic cyst wall specimens obtained using micro-forceps for improving diagnostic accuracy by Stuart Astbury, Aishwarya Baskar, Jane I. Grove, Philip Kaye, Aloysious D. Aravinthan, Martin W. James, Christopher Clarke, Guruprasad P. Aithal, Suresh Vasan Venkatachalapathy

    Published 2023-10-01
    Get full text
    Article
  7. 7
    Estimating the clinical prevalence of Wilson’s disease in the UK

    Estimating the clinical prevalence of Wilson’s disease in the UK by Pramudi Wijayasiri, Jatinder Hayre, Edward S. Nicholson, Philip Kaye, Emilie A. Wilkes, Jonathan Evans, Guruprasad P. Aithal, Gabriela Jones, Fiona Pearce, Aloysious D. Aravinthan

    Published 2021-10-01
    Get full text
    Article
  8. 8
    The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis.

    The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis. by Terry W Bilverstone, Megan Garland, Rory J Cave, Michelle L Kelly, Martina Tholen, Donna M Bouley, Philip Kaye, Nigel P Minton, Matthew Bogyo, Sarah A Kuehne, Roman A Melnyk

    Published 2020-09-01
    Get full text
    Article

Search Tools: